You are here

  • Home
  • Archive
  • Volume 12, Issue 3
  • Interruptions of biological and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: a descriptive cohort study assessing trends in patient characteristics in Switzerland

Article metrics

Article menu
Rheumatology
Original research
Interruptions of biological and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: a descriptive cohort study assessing trends in patient characteristics in Switzerland

 

Online download statistics by month:

Online download statistics by month: March 2022 to September 2024

AbstractFullPdf
Mar 202271770773
Apr 202218918966
May 202210210045
Jun 2022908916
Jul 202214013827
Aug 2022514915
Sep 2022505016
Oct 2022504711
Nov 2022413717
Dec 2022373510
Jan 202327258
Feb 2023272412
Mar 2023282813
Apr 2023232213
May 2023181411
Jun 202321169
Jul 2023221910
Aug 2023242310
Sep 202317174
Oct 202333314
Nov 202335379
Dec 202321219
Jan 202444324
Feb 2024252512
Mar 202413109
Apr 2024323116
May 2024252511
Jun 2024282312
Jul 2024292520
Aug 202418158
Sep 2024552
Total19821909502